The substantial outperformance of Medpace Holdings compared to the market, as evidenced by its 48.67% annualized return over the past 5 years, indicates strong company performance and management. This level of growth, especially in a company with a now $12.11 billion market cap, is likely to attract more investors, potentially driving the stock price up in the short term.